ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro
- 1 May 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 207 (1) , 43-50
- https://doi.org/10.1016/s0922-4106(05)80036-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Structure‐Activity Studies on the Neuroactive and Neurotropic Effects of Neuropeptides Related to ACTHAnnals of the New York Academy of Sciences, 1988
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Liposome‐mediated labeling of adrenocorticotropin fragments parallels their biological activityFEBS Letters, 1983
- The effect of ACTH on rat brain synaptic plasma membrane lipid fluidityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1982
- Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects.Physiological Reviews, 1982
- The Modulation of Protein Phosphorylation and Receptor Binding in Synaptic Membranes by Changes in Lipid Fluidity: Implications for AgeingPublished by Elsevier ,1982
- Binding of 3H-β-endorphin to rat brain membranes: Characterization of opiate properties and interaction with ACTHEuropean Journal of Pharmacology, 1980
- 3H-N-n-propylnorapomorphine: A novel agonist ligand for central dopamine receptorsEuropean Journal of Pharmacology, 1979
- Histamine H1-receptors in brain labeled with 3H-mepyramineEuropean Journal of Pharmacology, 1978
- Interaction between acth fragments, brain opiate receptors and morphine-induced analgesiaEuropean Journal of Pharmacology, 1976